Literature DB >> 14644176

Imitating the humoral immune response.

Arne Skerra1.   

Abstract

The immune system makes use of two distinct mechanisms to mount an efficient response against almost every foreign macromolecular substance. First, antibodies with their robust immunoglobulin domain architecture provide a rigid scaffold to support six hypervariable loops, capable of forming highly diverse binding sites. Second, an efficient genetic mechanism has evolved to create sequence diversity at the somatic level in a step-wise process, whereby random recombination of an inherited set of gene segments is followed by hypermutation events. Insight into the corresponding molecular mechanisms is developing rapidly and enables adaptation of the emerging principles to the creation of artificial binding proteins in vitro, using the techniques of combinatorial biotechnology. Thus, novel types of receptor molecules have been constructed from alternative scaffolds, including alpha-helical bundle and beta-barrel proteins. These may provide superior tools for the recognition, targeting or separation of a wide range of biomolecular structures or substances in biological research, technology, and even medicine.

Mesh:

Substances:

Year:  2003        PMID: 14644176     DOI: 10.1016/j.cbpa.2003.10.012

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  10 in total

Review 1.  Research and development of next generation of antibody-based therapeutics.

Authors:  Jing Li; Zhenping Zhu
Journal:  Acta Pharmacol Sin       Date:  2010-08-09       Impact factor: 6.150

Review 2.  Beyond Antibodies as Binding Partners: The Role of Antibody Mimetics in Bioanalysis.

Authors:  Xiaowen Yu; Yu-Ping Yang; Emre Dikici; Sapna K Deo; Sylvia Daunert
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2017-03-24       Impact factor: 10.745

3.  NMR structure and dynamics of the engineered fluorescein-binding lipocalin FluA reveal rigidification of beta-barrel and variable loops upon enthalpy-driven ligand binding.

Authors:  Jeffrey L Mills; Gaohua Liu; Arne Skerra; Thomas Szyperski
Journal:  Biochemistry       Date:  2009-08-11       Impact factor: 3.162

4.  Engineering isoflavone metabolism with an artificial bifunctional enzyme.

Authors:  L Tian; R A Dixon
Journal:  Planta       Date:  2006-02-16       Impact factor: 4.116

Review 5.  Miniproteins as phage display-scaffolds for clinical applications.

Authors:  Frederic Zoller; Uwe Haberkorn; Walter Mier
Journal:  Molecules       Date:  2011-03-14       Impact factor: 4.411

Review 6.  Scavenging Bacterial Siderophores with Engineered Lipocalin Proteins as an Alternative Antimicrobial Strategy.

Authors:  Martin Dauner; Arne Skerra
Journal:  Chembiochem       Date:  2019-12-13       Impact factor: 3.164

Review 7.  Structural plasticity in the loop region of engineered lipocalins with novel ligand specificities, so-called Anticalins.

Authors:  S Achatz; A Jarasch; A Skerra
Journal:  J Struct Biol X       Date:  2021-11-30

8.  A segment of cold shock protein directs the folding of a combinatorial protein.

Authors:  Stephanie de Bono; Lutz Riechmann; Eric Girard; Roger L Williams; Greg Winter
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-25       Impact factor: 11.205

Review 9.  Anticalin® Proteins as Therapeutic Agents in Human Diseases.

Authors:  Christine Rothe; Arne Skerra
Journal:  BioDrugs       Date:  2018-06       Impact factor: 5.807

10.  Engineering a Highly Active Sucrose Isomerase for Enhanced Product Specificity by Using a "Battleship" Strategy.

Authors:  Patrick Pilak; André Schiefner; Judith Seiboth; Johannes Oehrlein; Arne Skerra
Journal:  Chembiochem       Date:  2020-04-16       Impact factor: 3.164

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.